The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)
Abstract
:1. Introduction
2. The Economic Case for Prevention
3. Impediments to Prevention
4. The Content of Prevention
5. Evaluation of Prevention
6. Risk Factors for ME/CFS
7. Infections
8. Immunological Factors
9. Occupational Exposures
10. Psychological Factors
11. Children and Adolescents
12. Other Possible Risk Factors
13. Perpetuating Factors
14. Scope for Prevention in ME/CFS
15. Associated Features
16. Conclusions and Recommendations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lindan, R. Benign Myalgic Encephalomyelitis. Can. Med. Assoc. J. 1956, 75, 596–597. [Google Scholar]
- Acheson, E.D. The clinical syndrome variously called myalgic encephalomyelitis, Iceland disease and epidemic neurom-yasthenis. Am. Med. 1959, 26, 589–595. [Google Scholar] [CrossRef]
- Carruthers, B.M.; Jain, A.K.; De Meirleir, K.L.; Peterson, D.L.; Klimas, N.G.; Lerner, A.M.; Bested, A.C.; Flor-Henry, P.; Joshi, P.; Powles, A.C.P.; et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003, 11, 7–116. [Google Scholar] [CrossRef]
- Institute of Medicine (IOM). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness; The National Academies Press: Washington, DC, USA, 2015.
- Johnstone, S.C.; Staines, D.R.; Marshall-Gradisnik, S.M. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin. Epidemiol. 2016, 8, 97–107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pheby, D.; Lacerda, E.; Nacul, L.; Drachler, M.D.L.; Campion, P.; Howe, A.; Poland, F.; Curran, M.; Featherstone, V.; Fayyaz, S.; et al. A Disease Register for ME/CFS: Report of a Pilot Study. BMC Res. Notes 2011, 4, 139. [Google Scholar] [CrossRef]
- Lloyd, A.R.; Hickie, I.; Boughton, C.R. Prevalence of chronic fatigue syndrome in an Australian population. Med. J. Aust. 1990, 153, 522–528. [Google Scholar] [CrossRef] [PubMed]
- Pheby, D.F.; Araja, D.; Berkis, U.; Brenna, E.; Cullinan, J.; De Korwin, J.-D.; Gitto, L.A.; Hughes, D.; Hunter, R.M.; Trepel, D.; et al. The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE). Healthcare 2020, 8, 88. [Google Scholar] [CrossRef] [Green Version]
- Owen, L.; Fischer, A. The cost-effectiveness of public health interventions examined by the National Institute for Health and Care Excellence from 2005 to 2018. Public Health 2019, 169, 151–162. [Google Scholar] [CrossRef]
- Newton, J.; Ferguson, B. 6 September 2017-Health economics. Available online: www.gov.uk (accessed on 18 March 2020).
- Benson, B.L.; Storey, E.; Huntington, C.G.; Eberle, M.U.; Ferris, A.M. The Economic Impact of Prevention: A report prepared by The Center for Public Health and Health Policy at The University of Connecticut Health Center and The University of Connecticut, Storrs, Niger. J. Clin. Pract. 2008, 19, 161. [Google Scholar]
- Edwards, R.T.; McIntosh, E. Handbooks in Health Economic Evaluation; Oxford University Press: Oxford, UK, 2019. [Google Scholar]
- Goede, S.L.; Kuntz, K.M.; van Ballegooijen, M.; Knudsen, A.B.; Lansdorp-Vogelaar, I.; Tangka, F.K.; Howard, D.H.; Chin, J.; Zauber, A.G.; Seeff, L.C. Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening. Med. Care 2015, 53, 630–638. [Google Scholar] [CrossRef] [Green Version]
- Dubas-Jakóbczyk, K.; Kocot, E.; Kissimova-Skarbek, K.; Huter, K.; Rothgang, H. Economic evaluation of health promotion and primary prevention actions for older people—A systematic review. Eur. J. Public Health 2017, 27, 670–679. [Google Scholar] [CrossRef] [Green Version]
- Masters, R.; Anwar, E.; Collins, B.; Cookson, R.; Capewell, S. Return on investment of public health interventions: A systematic review. J. Epidemiol. Community Health 2017, 71, 827–834. [Google Scholar] [CrossRef] [Green Version]
- Warner, K.E. The economic implications of preventive health care. Soc. Sci. Med. Part. C Med. Econ. 1979, 13, 227–237. [Google Scholar] [CrossRef] [Green Version]
- Oldridge, N.; Taylor, R.S. Cost-effectiveness of exercise therapy in patients with coronary heart disease, chronic heart failure and associated risk factors: A systematic review of economic evaluations of randomized clinical trials. Eur. J. Prev. Cardiol. 2020, 27, 1045–1055. [Google Scholar] [CrossRef] [PubMed]
- Rohde, L.E.; Bertoldi, E.G.; Goldraich, L.; Polanczyk, C.A. Cost-effectiveness of heart failure therapies. Nat. Rev. Cardiol. 2013, 10, 338–354. [Google Scholar] [CrossRef] [PubMed]
- Beaton, T. How Preventive Healthcare Services Reduce Spending for Payers. In Value-Based Care News; Health Payer Intelligence: Danvers, MA, USA, 2017. [Google Scholar]
- Musich, S.; Wang, I.S.; Hawkins, J.K.; Klemes, A. The Impact of Personalized Preventive Care on Health Care Quality, Utilization, and Expenditures. Popul. Health Manag. 2016, 19, 389–397. [Google Scholar] [CrossRef] [Green Version]
- Sharon, S.C.; Connolly, I.M.; Murphree, K.R. A review of the literature: The economic impact of preventive dental hygiene services. J. Dent. Hyg. JDH 2005, 79, 11. [Google Scholar]
- Miller, W.; Rein, D.; O’Grady, M.; Yeung, J.-E.; Eichner, J.; McMahon, M. A review and analysis of economic models of prevention benefits. In April 2013 U.S. Department of Health & Human Services. ASPE: Office of the Assistant Secretary for Planning and Evaluation. Available online: https://aspe.hhs.gov/basic-report/review-and-analysis-economic-models-prevention-benefits (accessed on 15 April 2021).
- Woolf, S.H.; Husten, C.G.; Lewin, L.S.; Marks, J.S.; Fielding, J.E.; Sanchez, E.J. The Economic Argument for Disease Prevention: Distinguishing Between Value and Savings. A Prevention Policy Paper Commissioned by Partnership for Prevention (on behalf of the National Commission on Prevention Priorities (NCPP)). 2009. Available online: https://www.coursehero.com/file/66910396/EconomicValue-Preventionpdf/ (accessed on 8 March 2021).
- Pauly, M.V.; Sloan, F.A.; Sullivan, S.D. An Economic Framework for Preventive Care Advice. Health Aff. 2014, 33, 2034–2040. [Google Scholar] [CrossRef]
- Weatherly, H.; Drummond, M.; Claxton, K.; Cookson, R.; Ferguson, B.; Godfrey, C.; Rice, N.; Sculpher, M.; Sowden, A. Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations. Health Policy 2009, 93, 85–92. [Google Scholar] [CrossRef]
- Marmot, M. The Status Syndrome; Henry Holt: New York, NY, USA, 2004. [Google Scholar]
- Marshall, L. The economic case for preventing ill health. The Health Foundation. 2016. Available online: https://www.health.org.uk/blogs/the-economic-case-for-preventing-ill-health (accessed on 15 April 2001).
- McDaid, D.; Sassi, F.; Merkur, S. Promoting Health, Preventing Disease: The Economic Case; Open University Press: Maidenhead, UK, 2015; pp. 3–18. [Google Scholar]
- World Health Organization (WHO). Preventing Chronic Diseases: A Vital Investment; World Health Organization: Geneva, Switzerland, 2005. [Google Scholar]
- Drummond, M.; Sculpher, M.; Claxton, K.; Stoddart, G.L.; Torrance, G. Methods for the Economic Evaluation of Health Care Programmes; Oxford University Press: Oxford, UK, 2015. [Google Scholar]
- Jones, C.; Hartfiel, N.; Brocklehurst, P.; Lynch, M.; Edwards, R.T. Social Return on Investment Analysis of the Health Precinct Community Hub for Chronic Conditions. Int. J. Environ. Res. Public Health 2020, 17, 5249. [Google Scholar] [CrossRef] [PubMed]
- National Institute for Health and Care Excellence. Methods for the Development of NICE Public Health Guidance, 3rd ed.; National Institute for Health and Care Excellence: London, UK, 2012. [Google Scholar]
- Scheibenbogen, C.; Freitag, H.; Blanco, J.; Capelli, E.; Lacerda, E.; Authier, J.; Meeus, M.; Marrero, J.C.; Nora-Krukle, Z.; Oltra, E.; et al. The European ME/CFS Biomarker Landscape project: An initiative of the European network EUROMENE. J. Transl. Med. 2017, 15, 162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morris, G.; Maes, M.; Berk, M.; Puri, B.K. Myalgic encephalomyelitis or chronic fatigue syndrome: How could the illness develop? Metab. Brain Dis. 2019, 34, 385–415. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miller, G. Molecular approaches to epidemiologic evaluation of viruses as risk factors for patients who have chronic fatigue syndrome. Rev. Infect. Dis. 1991, 13, 22–119. [Google Scholar] [CrossRef]
- Rasa, S.; Nora-Krukle, Z.; Henning, N.; Eliassen, E.; Shikova, E.; Harrer, T.; Scheibenbogen, C.; Murovska, M.; Prusty, B.K. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 2018, 16, 1–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Katz, B.Z.; Shiraishi, Y.; Mears, C.J.; Binns, H.J.; Taylor, R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics 2009, 124, 189–193. [Google Scholar] [CrossRef] [Green Version]
- Candy, B.; Chalder, T.; Cleare, A.J.; Wessely, S.; White, P.D.; Hotopf, M. Recovery from infectious mononucleosis: A case for more than symptomatic therapy? A systematic review. Br. J. Gen. Pract. 2002, 52, 844–851. [Google Scholar]
- White, P.D.; Thomas, J.M.; Amess, J.; Crawford, D.H.; Grover, S.A.; Kangro, H.O.; Clare, A.W. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br. J. Psychiatry 1998, 173, 475–481. [Google Scholar] [CrossRef]
- Possible Causes|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|CDC. Available online: https://www.cdc.gov/me-cfs/about/possible-causes.html#:~:text=People%20with%20ME%2FCFS%20often%20have%20their%20illness%20begin,of%20symptoms%20that%20meet%20the%20criteria%20for%20ME%2FCFS. (accessed on 8 January 2021).
- Donnachie, E.; Schneider, A.; Mehring, M.; Enck, P. Incidence of irritable bowel syndrome and chronic fatigue following GI infection: A population-level study using routinely collected claims data. Gut 2017, 67, 1078–1086. [Google Scholar] [CrossRef]
- Khan, F.; Kennedy, G.; Spence, V.A.; Newton, D.J.; Belch, J.J.F. Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure. Clin. Sci. 2004, 106, 183–189. [Google Scholar] [CrossRef]
- Levine, P.H.; Snow, P.G.; Ranum, A.B.; Paul, C.; Holmes, M.J. Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Arch. Intern. Med. 1997, 157, 750–754. [Google Scholar] [CrossRef]
- Manian, F.A. Simultaneous measurement of antibodies to Epstein–Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: Is there evidence of activation of a nonspecifc polyclonal immune response? Clin. Infect. Dis. 1994, 19, 448–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Corrigan, F.; Macdonald, S.; Brown, A.; Armstrong, K.; Armstrong, E. Neurasthenic fatigue, chemical sensitivity and GABAa receptor toxins. Med. Hypotheses 1994, 43, 195–200. [Google Scholar] [CrossRef]
- Fernandez-Sola, J.; Lluis Padierna, M.; Nogue Xarau, S.; Munne Mas, P. Chronic fatigue syndrome and multiple chemical hypersensitivity after insecticide exposure. Med. Clin. 2005, 124, 451–453. [Google Scholar]
- Tahmaz, N.; Soutar, A.; Cherrie, J. Chronic fatigue and organophosphate pesticides in sheep farming: A retrospective study amongst people reporting to a UK pharmacovigilance scheme. Ann. Occup. Hyg. 2003, 47, 261–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Opinion on possible links between BSE and Organophosphates used as pesticides against ecto- and endoparasites in cattle Report and opinion adopted at the Scientific Steering Committee meeting of 25–26 June 1998. Available online: https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_ssc_out18_en.pdf. (accessed on 6 January 2021).
- Ray, E.D. Pesticide neurotoxicity in Europe: Real risks and perceived risks. NeuroToxicology 2000, 21, 219–221. [Google Scholar] [PubMed]
- Jackson, C.A.; Spurgeon, A. Symptom-Reporting Following Occupational Exposure to Organophosphate Pesticides in Sheep Dip (Institute of Occupational Health University of Birmingham). Available online: https://www.hse.gov.uk/research?crr_pdf/1995/crr95074.pdf (accessed on 6 January 2021).
- Kennedy, G.; Abbot, N.C.; Spence, V.; Underwood, C.; Belch, J.J. The specificity of the CDC-1994 criteria for chronic fatigue syndrome: Comparison of health status in three groups of patients who fulfill the criteria. Ann. Epidemiol. 2004, 14, 95–100. [Google Scholar] [CrossRef] [PubMed]
- Fukuda, K.; Straus, S.E.; Hickie, I.; Sharpe, M.C.; Dobbins, J.G.; Komaroff, A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern Med. 1994, 15, 953–959. [Google Scholar] [CrossRef] [PubMed]
- Behan, P.O. Chronic Fatigue Syndrome as a Delayed Reaction to Chronic Low-dose Organophosphate Exposure. J. Nutr. Environ. Med. 1996, 6, 341–350. [Google Scholar] [CrossRef]
- Kaushik, N.; Fear, D.; Richards, S.C.M.; McDermott, C.R.; Nuwaysir, E.F.; Kellam, P.; Harrison, T.J.; Wilkinson, R.J.; Tyrrell, D.A.J.; Holgate, S.T.; et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J. Clin. Pathol. 2005, 58, 826–832. [Google Scholar] [CrossRef] [PubMed]
- Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 5 Organophosphates (epa.gov). Available online: https://www.epa.gov/sites/production/files/documents/rmpp_6thed_ch5_organophosphates.pdf (accessed on 6 January 2021).
- Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic effects (epa.gov). Available online: https://www.epa.gov/sites/production/files/documents/rmpp_6thed_ch21_chroniceffects.pdf (accessed on 6 January 2021).
- Dassanayake, T.; Weerasinghe, V.; Dangahadeniya, U.; Kularatne, K.; Dawson, A.; Karalliedde, L. Cognitive processing of visual stimuli in patients with organophosphate insecticide poisoning. Neurology 2007, 68, 2027–2030. [Google Scholar] [CrossRef]
- Ray, D.E.; Richards, P. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol. Lett. 2001, 120, 343–351. [Google Scholar] [CrossRef]
- Terry, A.; Beck, W.; Warner, S.; Vandenhuerk, L.; Callahan, P. Chronic impairments in spatial learning and memory in rats previously exposed to chlorpyrfos or diisopropylfluorophosphate. Neurotoxicol. Teratol. 2012, 34, 1–8. [Google Scholar] [CrossRef] [Green Version]
- Dunstan, R.H.; Roberts, T.K.; Donohoe, M.; McGregor, N.R.; Hope, D.; Taylor, W.G.; Watkins, A.J.; Murdoch, R.N.; Butt, H.L. Bioaccumulated chlorinated hydrocarbons and red/white blood cell parameters. Biochem. Mol. Med. 1996, 58, 77–84. [Google Scholar] [CrossRef]
- Dunstan, R.H.; Donohoe, M.; Taylor, W.; Roberts, T.K.; Murdoch, R.N.; Watkins, A.J.; McGregor, N.R. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med. J. Aust. 1995, 163, 294–297. [Google Scholar] [CrossRef] [PubMed]
- Overstreet, D.H.; Djuric, V. A genetic rat model of cholinergic hypersensitivity: Implications for chemical intolerance, chronic fatigue, and asthma. Ann. N. Y. Acad. Sci. 2001, 933, 92–102. [Google Scholar] [CrossRef] [PubMed]
- Levine, P.H.; Atherton, M.; Fears, T.; Hoover, R. An Approach to Studies of Cancer Subsequent to Clusters of Chronic Fatigue Syndrome: Use of Data from the Nevada State Cancer Registry. Clin. Infect. Dis. 1994, 18, S49–S53. [Google Scholar] [CrossRef] [PubMed]
- Levine, P.H.; Peterson, D.; McNamee, F.L.; O’Brien, K.; Gridley, G.; Hagerty, M.; Brady, J.; Fears, T.; Atherton, M.; Hoover, R. Does chronic fatigue syndrome predispose to non-Hodgkin’s lymphoma? Cancer Res. 1992, 52, 5516s–5518s. [Google Scholar] [PubMed]
- Levine, P.H.; Fears, T.R.; Cummings, P.; Hoover, R.N. Cancer and a fatiguing illness in Northern Nevada-A causal hypothesis. Ann. Epidemiol. 1998, 8, 245–249. [Google Scholar] [CrossRef]
- Daugherty, S.A.; Henry, B.E.; Peterson, D.L.; Swarts, R.L.; Bastien, S.; Thomas, R.S. Chronic Fatigue Syndrome in Northern Nevada. Clin. Infect. Dis. 1991, 13, S39–S44. [Google Scholar] [CrossRef] [PubMed]
- Nacul, L.C.; Lacerda, E.M.; Sakellariou, D. Is there an association between exposure to chemicals and chronic fatigue syndrome? Review of the evidence. Bulletin IACFS/ME 2009, 17, 4. [Google Scholar]
- Brooks, S.K.; Chalder, T.; Rimes, K.A. Chronic Fatigue Syndrome: Cognitive, Behavioural and Emotional Processing Vulnerability Factors. Behav. Cogn. Psychother. 2017, 45, 156–169. [Google Scholar] [CrossRef] [Green Version]
- Saez-Francas, N.; Calvo, N.; Alegre, J.; Castro-Marrero, J.; Ramirez, N.; Hernandez-Vara, J.; Casas, M. Childhood trauma in Chronic Fatigue Syndrome: Focus on personality disorders and psychopathology. Compr. Psychiatry 2015, 62, 13–19. [Google Scholar] [CrossRef] [PubMed]
- Warren, J.W.; Langenberg, P.; Clauw, D.J. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J. Psychosom. Res. 2013, 74, 12–17. [Google Scholar] [CrossRef]
- Tofoli, L.F.; Andrade, L.H.; Fortes, S. Somatization in Latin America: A review of the classification of somatoform disorders, functional syndromes and medically unexplained symptoms. Rev. Bras. Psiquiatr. 2011, 33 (Suppl. 1), S59–S80. [Google Scholar]
- Van Oudenhove, L.; Vandenberghe, J.; Vos, R.; Holvoet, L.; Tack, J. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia. Neurogastroenterol. Motil. 2011, 23, 202–524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wong, W.S.; Fielding, R. Prevalence of chronic fatigue among Chinese adults in Hong Kong: A population-based study. J. Affect. Disord. 2010, 127, 248–256. [Google Scholar] [CrossRef]
- Nater, U.M.; Jones, J.F.; Lin, J.-M.S.; Maloney, E.; Reeves, W.C.; Heim, C. Personality Features and Personality Disorders in Chronic Fatigue Syndrome: A Population-Based Study. Psychother. Psychosom. 2010, 79, 312–318. [Google Scholar] [CrossRef] [Green Version]
- Kato, K.; Sullivan, P.F.; Evengård, B.; Pedersen, N.L. Premorbid Predictors of Chronic Fatigue. Arch. Gen. Psychiatry 2006, 63, 1267–1272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moss-Morris, R.; Spence, M. To “Lump” or to “Split” the Functional Somatic Syndromes: Can Infectious and Emotional Risk Factors Differentiate Between the Onset of Chronic Fatigue Syndrome and Irritable Bowel Syndrome? Psychosom. Med. 2006, 68, 463–469. [Google Scholar] [CrossRef] [PubMed]
- Fisher, L.; Chalder, T. Childhood experiences of illness and parenting in adults with chronic fatigue syndrome. J. Psychosom. Res. 2003, 54, 439–443. [Google Scholar] [CrossRef]
- Heim, C.; Nater, U.M.; Maloney, E.; Boneva, R.; Jones, J.F.; Reeves, W.C. Childhood trauma and risk for chronic fatigue syndrome: Association with neuroendocrine dysfunction. Arch. Gen. Psychiatry 2009, 66, 72–80. [Google Scholar] [CrossRef] [Green Version]
- Heim, C.; Wagner, D.; Maloney, E.; Papanicolaou, D.A.; Solomon, L.; Jones, J.F.; Unger, E.R.; Reeves, W.C. Early adverse experience and risk for chronic fatigue syndrome: Results from a population-based study. Arch. Gen. Psychiatry 2006, 63, 1258–1266. [Google Scholar] [CrossRef] [Green Version]
- Bhui, K.S.; Dinos, S.; Ashby, D.; Nazroo, J.; Wessely, S.; White, P.D. Chronic fatigue syndrome in an ethnically diverse population: The influence of psychosocial adversity and physical inactivity. BMC Med. 2011, 9, 26. [Google Scholar] [CrossRef] [PubMed]
- Harvey, S.B.; Wadsworth, M.; Wessely, S.; Hotopf, M. The relationship between prior psychiatric disorder and chronic fatigue: Evidence from a national birth cohort study. Psychol. Med. 2007, 38, 933–940. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Collin, S.M.; Norris, T.; Nuevo, R.; Tilling, K.; Joinson, C.; Sterne, J.A.; Crawley, E. Chronic Fatigue Syndrome at Age 16 Years. Pediatry 2016, 137, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Collin, S.M.; Tilling, K.; Joinson, C.; Rimes, K.A.; Pearson, R.M.; Hughes, R.A.; Sterne, J.A.; Crawley, E. Maternal and Childhood Psychological Factors Predict Chronic Disabling Fatigue at Age 13 Years. J. Adolesc. Health 2015, 56, 181–187. [Google Scholar] [CrossRef] [Green Version]
- Crawley, E. The epidemiology of chronic fatigue syndrome/myalgic encephalitis in children. Arch. Dis. Child. 2014, 99, 171–174. [Google Scholar] [CrossRef]
- Ter Wolbeek, M.; Van Doornen, L.J.; Kavelaars, A.; Tersteeg-Kamperman, M.D.; Heijnen, C.J. Fatigue, depressive symptoms, and anxiety from adolescence up to young adulthood: A longitudinal study. Brain Behav. Immun. 2011, 25, 1249–1255. [Google Scholar] [CrossRef]
- Vangeel, E.; Van Den Eede, F.; Hompes, T.; Izzi, B.; Del Favero, J.; Moorkens, G.; Lambrechts, D.; Freson, K.; Claes, S. Chronic Fatigue Syndrome and DNA Hypomethylation of the Glucocorticoid Receptor Gene Promoter 1F Region: Associations with HPA Axis Hypofunction and Childhood Trauma. Psychosom. Med. 2015, 77, 853–862. [Google Scholar] [CrossRef] [PubMed]
- Hempel, S.; Chambers, D.; Bagnall, A.-M.; Forbes, C. Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: A systematic scoping review of multiple predictor studies. Psychol. Med. 2007, 38, 915–926. [Google Scholar] [CrossRef] [PubMed]
- Viner, R.; Hotopf, M. Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: National birth cohort study. BMJ 2004, 329, 941. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jason, L.A.; Porter, N.; Hunnell, J.; Rademaker, A.; Richman, J.A. CFS prevalence and risk factors over time. J. Health Psychol. 2010, 16, 445–456. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hickie, I.; Lloyd, A.; Wakefield, D.; Parker, G. The Psychiatric Status of Patients with the Chronic Fatigue Syndrome. Br. J. Psychiatry 1990, 156, 534–540. [Google Scholar] [CrossRef]
- Underhill, R.; O’Gorman, R. Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients. J. Chronic Fatigue Syndr. 2006, 13, 3–13. [Google Scholar] [CrossRef]
- Underhill, R. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease. Med. Hypotheses 2015, 85, 765–773. [Google Scholar] [CrossRef]
- Rusu, C.; Gee, M.E.; Lagace, C.; Parlor, M. Chronic fatigue syndrome and fibromyalgia in Canada: Prevalence and associations with six health status indicators. Health Promot. Chronic Dis. Prev. Can. 2015, 35, 3–11. [Google Scholar] [CrossRef]
- Muller, A.E.; Tveito, K.; Bakken, I.J.; Flottorp, S.A.; Mjaaland, S.; Larun, L. Potential causal factors of CFS/ME: A concise and systematic scoping review of factors researched. J. Transl. Med. 2020, 18, 1–7. [Google Scholar] [CrossRef]
- Boneva, R.S.; Maloney, E.M.; Lin, J.-M.; Jones, J.F.; Wieser, F.; Nater, U.M.; Heim, C.M.; Reeves, W.C. Gynecological History in Chronic Fatigue Syndrome: A Population-Based Case-Control Study. J. Women Health 2011, 20, 21–28. [Google Scholar] [CrossRef] [Green Version]
- Dinos, S.; Khoshaba, B.; Ashby, D.; White, P.D.; Nazroo, J.; Wessely, S.; Bhui, K.S. A systematic review of chronic fatigue, its syndromes and ethnicity: Prevalence, severity, co-morbidity and coping. Int. J. Epidemiol. 2009, 38, 1554–1570. [Google Scholar] [CrossRef] [Green Version]
- Ter Wolbeek, M.; Van Doornen, L.J.; Kavelaars, A.; Heijnen, C.J. Severe Fatigue in Adolescents: A Common Phenomenon? Pediatry 2006, 117, e1078–e1086. [Google Scholar] [CrossRef]
- Huibers, M.J.H.; Kant, I.J.; Knottnerus, J.A.; Bleijenberg, G.; Swaen, G.M.H.; Kasl, S.V. Development of the chronic fatigue syndrome in severely fatigued employees: Predictors of outcome in the Maastricht cohort study. J. Epidemiol. Community Health 2004, 58, 877–882. [Google Scholar] [CrossRef] [Green Version]
- Kennedy, G.; Spence, V.A.; McLaren, M.; Hill, A.; Underwood, C.; Belch, J.J. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 2005, 39, 584–589. [Google Scholar] [CrossRef] [PubMed]
- Gaab, J.; Engert, V.; Heitz, V.; Schad, T.; Schürmeyer, T.H.; Ehlert, U. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. J. Psychosom. Res. 2004, 56, 419–424. [Google Scholar] [CrossRef]
- Jain, V.; Arunkumar, A.; Kingdon, C.; Lacerda, E.; Nacul, L. Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS. BMC Neurol. 2017, 17, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Lacerda, E.M.; Geraghty, K.; Kingdon, C.C.; Palla, L.; Nacul, L.; Kingdon, C. A logistic regression analysis of risk factors in ME/CFS pathogenesis. BMC Neurol. 2019, 19, 275. [Google Scholar] [CrossRef]
- Joyce, J.; Hotopf, M.; Wessely, S. The prognosis of chronic fatigue and chronic fatigue syndrome: A systematic review. Int. J. Med. 1997, 90, 223–233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Skapinakis, P.; Lewis, G.; Mavreas, V. One-year outcome of unexplained fatigue syndromes in primary care: Results from an international study. Psychol. Med. 2003, 33, 857–866. [Google Scholar] [CrossRef]
- van Geelen, S.M.; Bakker, R.J.; Kuis, W.; van de Putte, E.M. Adolescent chronic fatigue syndrome: A follow-up study. Arch. Pediatrics Adolesc. Med. 2010, 164, 810–814. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maes, M.; Mihaylova, I.; Kubera, M.; Uytterhoeven, M.; Vrydags, N.; Bosmans, E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome. Neuroendocrinol. Lett. 2009, 30, 15–22. [Google Scholar]
- Maes, M.; Mihaylova, I.; Kubera, M.; Uytterhoeven, M.; Vrydags, N.; Bosmans, E. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol. Lett. 2009, 30, 470–476. [Google Scholar]
- Bell, K.M.; Cookfair, D.; Bell, D.S.; Reese, P.; Cooper, L. Risk Factors Associated with Chronic Fatigue Syndrome in a Cluster of Pediatric Cases. Clin. Infect. Dis. 1991, 13, S32–S38. [Google Scholar] [CrossRef]
- Ortega-Hernandez, O.; Shoenfeld, Y. Infection, Vaccination, and Autoantibodies in Chronic Fatigue Syndrome, Cause or Coincidence? Ann. N. Y. Acad. Sci. 2009, 1173, 600–609. [Google Scholar] [CrossRef]
- Levine, P.H. Epidemiologic advances in chronic fatigue syndrome. J. Psychiatr. Res. 1997, 31, 7–18. [Google Scholar] [CrossRef]
- Pheby, D.; Saffron, L. Risk factors for severe ME/CFS. Biol. Med. 2009, 1, 50–74. [Google Scholar]
- Nisenbaum, R.; Jones, J.F.; Unger, E.R.; Reyes, M.; Reeves, W.C. A population-based study of the clinical course of chronic fatigue syndrome. Health Qual. Life Outcomes 2003, 1, 49. [Google Scholar] [CrossRef] [Green Version]
- Lin, J.-M.S.; Brimmer, D.J.; Boneva, R.S.; Jones, J.F.; Reeves, W.C. Barriers to healthcare utilization in fatiguing illness: A population-based study in Georgia. BMC Health Serv. Res. 2009, 9, 13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pheby, D.; Araja, D.; Berkis, U.; Brenna, E.; Cullinan, J.; de Korwin, J.-D.; Gitto, L.; Hughes, D.; Hunter, R.; Trepel, D.; et al. A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE). Medicina 2020, 57, 7. [Google Scholar] [CrossRef] [PubMed]
- Cullinan, J.; Pheby, D.; Araja, D.; Berkis, U.; Brenna, E.; de Korwin, J.-D.; Gitto, L.; Hughes, D.; Hunter, R.; Trepel, D.; et al. Perceptions of European ME/CFS Experts Concerning Knowledge and Understanding of ME/CFS among Primary Care Physicians in Europe: A Report from the European ME/CFS Research Network (EUROMENE). Medicina 2021, 57, 208. [Google Scholar] [CrossRef]
- Vink, M.; Vink-Niese, F. Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies. Diagnose 2019, 9, 124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kingdon, C.; Giotas, D.; Nacul, L.; Lacerda, E. Health Care Responsibility and Compassion-Visiting the Housebound Patient Severely Affected by ME/CFS. Healthcare 2020, 8, 197. [Google Scholar] [CrossRef]
- Cullinan, J.; Ni Chomrai, O.; Kindlon, T.; Black, L.; Casey, B. Understanding the economic impact of myalgic encephalo-myelitis/chronic fatigue syndrome (ME/CFS) in Ireland: A qualitative study. HRB Open Res. 2020, 3, 88. [Google Scholar] [CrossRef]
- Ardino, R.B.; Lorusso, L. La sindrome da affaticamento cronico/encefalomielite mialgica: Le caratteristiche della malattia e il ruolo dell’Associazione malati CFS [Myalgic encephalomyelitis/chronic fatigue syndrome: Characteristics of the disease and the role of the CFS patients’ association]. Politiche Sanit. 2018, 19, 91–95. [Google Scholar]
- Miwa, K.; Fujita, M. Cardiovascular Dysfunction with Low Cardiac Output Due to a Small Heart in Patients with Chronic Fatigue Syndrome. Intern. Med. 2009, 48, 1849–1854. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miwa, K. Small Heart as a Constitutive Factor Predisposing to Chronic Fatigue Syndrome; InTech: Rijeka, Croatia, 2012; ISBN 978-953-51-0072-0. [Google Scholar]
- Hurwitz, B.E.; Coryell, V.T.; Parker, M.; Martin, P.; LaPerriere, A.; Klimas, N.G.; Sfakianakis, G.N.; Bilsker, M.S. Chronic fatigue syndrome: Illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin. Sci. 2009, 118, 125–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miwa, K.; Fujita, M. Small Heart Syndrome in Patients with Chronic Fatigue Syndrome. Clin. Cardiol. 2008, 31, 328–333. [Google Scholar] [CrossRef]
- Miwa, K.; Fujita, M. Small heart with low cardiac output for orthostatic intolerance in patients with chronic fatigue syndrome. Clin. Cardiol. 2011, 34, 782–786. [Google Scholar] [CrossRef]
- Costigan, A.; Elliott, C.; McDonald, C.; Newton, J.L. Orthostatic symptoms predict functional capacity in chronic fatigue syndrome: Implications for management. Int. J. Med. 2010, 103, 589–595. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Centres for Disease Control. Treating the Most Disruptive Symptoms First and Preventing Worsening of Symptoms|Clinical Care of Patients|Healthcare Providers|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Available online: https://www.cdc.gov/me-cfs/healthcare-providers/clinical-care-patients-mecfs/treating-most-disruptive-symtoms.html (accessed on 6 April 2021).
- Medications for Postural Orthostatic Tachycardia Syndrome. Available online: https://www.drugs.com/condition/postural-orthostatic-tachycardia-syndrome.html (accessed on 6 April 2021).
- The European Human Biomonitoring Initiative (part of the H2020 Programme of the European Union). Available online: https://cordis.europa.eu/programme/id/H2020_SC1-PM-05-2016 (accessed on 9 January 2021).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pheby, D.F.H.; Araja, D.; Berkis, U.; Brenna, E.; Cullinan, J.; de Korwin, J.-D.; Gitto, L.; Hughes, D.A.; Hunter, R.M.; Trepel, D.; et al. The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE). Medicina 2021, 57, 388. https://doi.org/10.3390/medicina57040388
Pheby DFH, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin J-D, Gitto L, Hughes DA, Hunter RM, Trepel D, et al. The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE). Medicina. 2021; 57(4):388. https://doi.org/10.3390/medicina57040388
Chicago/Turabian StylePheby, Derek F. H., Diana Araja, Uldis Berkis, Elenka Brenna, John Cullinan, Jean-Dominique de Korwin, Lara Gitto, Dyfrig A. Hughes, Rachael M. Hunter, Dominic Trepel, and et al. 2021. "The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE)" Medicina 57, no. 4: 388. https://doi.org/10.3390/medicina57040388